rs141330288
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BS1_SupportingBP4
This summary comes from the ClinGen Evidence Repository: The NM_001114753.3: c.1447G>A variant in ENG is a missense variant predicted to cause substitution of valine by isoleucine at amino acid 483 (p.Val483Ile). The filtering allele frequency (the lower threshold of the 95% CI of 28/19926) of the c.1447G>A variant in ENG is 0.0009914 for East Asian chromosomes by gnomAD v2.1.1, which is higher than the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel threshold (>0.0008-0.002) for BS1_Supporting, and therefore meets this criterion (BS1_Supporting). The computational predictor REVEL gives a score of 0.094, which is below the threshold of ≤0.15, and the splice site predictor SpliceAI indicated that the variant has no impact on splicing, evidence that does not predict a damaging effect on ENG function (BP4). In summary, this variant meets the criteria to be classified as likely benign for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: BS1_Supporting, BP4 (specifications version 1.1.0; 02/04/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA5252756/MONDO:0008535/136
Frequency
Consequence
NM_001114753.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.1447G>A | p.Val483Ile | missense_variant | Exon 12 of 15 | ENST00000373203.9 | NP_001108225.1 | |
ENG | NM_000118.4 | c.1447G>A | p.Val483Ile | missense_variant | Exon 12 of 14 | NP_000109.1 | ||
ENG | NM_001278138.2 | c.901G>A | p.Val301Ile | missense_variant | Exon 12 of 15 | NP_001265067.1 | ||
LOC102723566 | NR_136302.1 | n.1426C>T | non_coding_transcript_exon_variant | Exon 3 of 6 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000374 AC: 57AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000177 AC: 44AN: 248718Hom.: 0 AF XY: 0.000193 AC XY: 26AN XY: 134724
GnomAD4 exome AF: 0.0000500 AC: 73AN: 1461444Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 727000
GnomAD4 genome AF: 0.000374 AC: 57AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74496
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 1 Uncertain:1Benign:1
The NM_001114753.3: c.1447G>A variant in ENG is a missense variant predicted to cause substitution of valine by isoleucine at amino acid 483 (p.Val483Ile). The filtering allele frequency (the lower threshold of the 95% CI of 28/19926) of the c.1447G>A variant in ENG is 0.0009914 for East Asian chromosomes by gnomAD v2.1.1, which is higher than the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel threshold (>0.0008-0.002) for BS1_Supporting, and therefore meets this criterion (BS1_Supporting). The computational predictor REVEL gives a score of 0.094, which is below the threshold of ≤0.15, and the splice site predictor SpliceAI indicated that the variant has no impact on splicing, evidence that does not predict a damaging effect on ENG function (BP4). In summary, this variant meets the criteria to be classified as likely benign for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: BS1_Supporting, BP4 (specifications version 1.1.0; 02/04/2025). -
The ENG c.1447G>A; p.Val483Ile variant (rs141330288), to our knowledge, is not reported in the medical literature but is reported as likely benign in ClinVar (Variation ID: 414304). This variant is found in the general population with an overall allele frequency of 0.02% (48/274678 alleles) in the Genome Aggregation Database, with an increased frequency of 0.1% in East Asians. The valine at codon 483 is weakly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. However, given the lack of clinical and functional data, the significance of the p.Val483Ile variant is uncertain at this time. -
ENG-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hereditary hemorrhagic telangiectasia Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at